复杂冠脉病变患者的血运重建选择与临床治疗进展

The Improvement of Revascularization and Effectiveness in Complex Coronary Disease

复杂冠脉病变是目前临床治疗中的热点及难点,近年来,随着内科介入治疗手段的不断发展,经皮冠状动脉介入治疗(PCI)取得了令人鼓舞的成绩,越来越多的患者和医生的将其血运重建策略成为首要选择,但冠状动脉旁路移植术(CABG)的优势是否从此就被取代了?在临床实践中,越来越多的研究成果表明:对每一个接受血运重建治疗的冠脉病变患者,只有仔细评价他们的冠脉病变特点以及获益风险比,才能够将危害降到最低,更大程度地发挥每种血运重建策略的优势。本文就近年来关于复杂冠脉病变的血运重建策略选择与治疗的相关研究进展作一综述。

Complex coronary disease is a hot and difficult point in clinical treatment at present.In recent years with the development of percutaneous coronary intervention（PCI）,PCI has received a great achievement,more and more patients and doctors take PCI as their first choice.Has CABG timereally passed？ However,in clinical practice,many researches show that： for every patient with coronary disease who receives revascularization of blood vessel,only by careful evaluation on the character of coronary disease and risk ratio,can they reach the lest damage and most benefit.This article tries to summarize the choice of revascularization of complex coronary disease and the progress of clinical treatment.